A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine
Yükleniyor...
Dosyalar
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Korean Coll Neuropsychopharmacology
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Rabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.
Açıklama
Anahtar Kelimeler
Rabbit syndrome, Sigma receptors, Side effect, Fluvoxamine, Serotonin Reuptake Inhibitors, Clinical-Implications, Tardive-Dyskinesia, Receptor Agonists, Chaperone, Ligands, Cortex, Brain, Scale
Kaynak
Clinical Psychopharmacology and Neuroscience
WoS Q Değeri
Q3
Scopus Q Değeri
Q2
Cilt
17
Sayı
1
